Earnings (Loss) Per Share (Tables)

9 Months Ended

Sep. 30, 2019

Earnings Per Share [Abstract]

Calculations of Earnings (Loss) Per Share

The calculations of earnings (loss) per share are as follows:

	Three Months Ended September 30,						Nine Months Ended September 30,
(In thousands, except per share amounts)	2019			2018			2019			2018
Basic earnings (loss) per Common Share:
(Loss) income from continuing operations, net of tax	$	(5,725	)	$	(12,141	)	$	(163,632	)	$	47,264
Net loss attributable to non-controlling interests		0			4			424			3,494
Net (loss) income from continuing operations attributable to    Allscripts Healthcare Solutions, Inc. stockholders	$	(5,725	)	$	(12,137	)	$	(163,208	)	$	50,758
Loss from discontinued operations, net of tax	$	0		$	(11,705	)	$	0		$	(25,353	)
Accretion of redemption preference on redeemable    convertible non-controlling interest - discontinued operations		0			(12,149	)		0			(36,446	)
Net loss from discontinued operations attributable to    Allscripts Healthcare Solutions, Inc. stockholders		0			(23,854	)		0			(61,799	)
Net loss attributable to Allscripts Healthcare    Solutions, Inc. stockholders	$	(5,725	)	$	(35,991	)	$	(163,208	)	$	(11,041	)
Weighted-average common shares outstanding		166,391			174,638			167,610			176,942
Basic (loss) earnings from continuing operations per    Common Share	$	(0.03	)	$	(0.07	)	$	(0.97	)	$	0.28
Basic loss from discontinued operations per Common Share		0.00			(0.13	)		0.00			(0.34	)
Net (loss) income attributable to Allscripts Healthcare    Solutions, Inc. stockholders per Common Share	$	(0.03	)	$	(0.20	)	$	(0.97	)	$	(0.06	)
Diluted earnings (loss) per Common Share:
(Loss) income from continuing operations, net of tax	$	(5,725	)	$	(12,141	)	$	(163,632	)	$	47,264
Net loss attributable to non-controlling interests		0			4			424			3,494
Net (loss) income from continuing operations attributable to    Allscripts Healthcare Solutions, Inc. stockholders	$	(5,725	)	$	(12,137	)	$	(163,208	)	$	50,758
Loss from discontinued operations, net of tax	$	0		$	(11,705	)	$	0		$	(25,353	)
Accretion of redemption preference on redeemable    convertible non-controlling interest - discontinued operations		0			(12,149	)		0			(36,446	)
Net loss from discontinued operations attributable to    Allscripts Healthcare Solutions, Inc. stockholders		0			(23,854	)		0			(61,799	)
Net (loss) income attributable to Allscripts Healthcare    Solutions, Inc. stockholders	$	(5,725	)	$	(35,991	)	$	(163,208	)	$	(11,041	)
Weighted-average common shares outstanding		166,391			174,638			167,610			176,942
Plus: Dilutive effect of stock options, restricted stock unit    awards and warrants		0			0			0			0
Weighted-average common shares outstanding assuming    dilution		166,391			174,638			167,610			176,942
Diluted (loss) earnings from continuing operations per    Common Share	$	(0.03	)	$	(0.07	)	$	(0.97	)	$	0.28
Diluted loss from discontinued operations per Common Share		0.00			(0.13	)		0.00			(0.34	)
Net (loss) income attributable to Allscripts Healthcare    Solutions, Inc. stockholders per Common Share	$	(0.03	)	$	(0.20	)	$	(0.97	)	$	(0.06	)

Anti-Dilutive Stock Options, Restricted Stock Unit Awards and Warrants Excluded from Computation of Diluted Earnings (Loss) Per Share

The following stock options, restricted stock unit awards and warrants are not included in the computation of diluted earnings (loss) per share as the effect of including such stock options, restricted stock unit awards and warrants in the computation would be anti-dilutive:

	Three Months Ended September 30,				Nine Months Ended September 30,
(In thousands)	2019		2018		2019		2018
Shares subject to anti-dilutive stock options, restricted stock    unit awards and warrants excluded from calculation		27,969		24,191		27,350		24,688